BrightSpring Health Services (NASDAQ:BTSG) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS

BrightSpring Health Services (NASDAQ:BTSG) posted its quarterly earnings data on Friday. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.40 by $0.05, FiscalAI reports. The firm had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.66 billion. BrightSpring Health Services had a return on equity of 14.63% and a net margin of 2.27%.The firm’s revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.22 EPS.

Here are the key takeaways from BrightSpring Health Services’ conference call:

• BrightSpring reported a strong second quarter, with revenue of $3.9 billion, up 23% year over year, and adjusted EBITDA of $206 million, up 44%, while EBITDA margin expanded 80 basis points to 5.3%.
• Specialty and infusion pharmacy revenue increased 30%, supported by 31% script growth and continued momentum in limited-distribution drugs; the company added two ultranarrow-network drugs, bringing its LDD portfolio to 155.
• Provider Services grew 30%, led by home health revenue growth of 51% and contributions from the Amedisys and LHC branches. BrightSpring raised its expected 2026 EBITDA contribution from those acquired assets to approximately $35 million.
• The Inflation Reduction Act is expected to reduce 2026 home and community pharmacy revenue by approximately $200 million, including about $45 million in each remaining quarter; management estimates the 2027 impact will be roughly half as large.
• BrightSpring reduced leverage to 2.15x, repaid approximately $300 million of term debt, refinanced at a 50-basis-point lower spread, and received credit-rating upgrades. Management now expects about $600 million of 2026 operating cash flow and year-end leverage below 2x before acquisitions, supporting additional M&A flexibility.

BrightSpring Health Services Stock Performance

NASDAQ BTSG opened at $59.71 on Friday. The stock has a fifty day simple moving average of $66.37 and a 200-day simple moving average of $51.86. The company has a current ratio of 1.74, a quick ratio of 1.38 and a debt-to-equity ratio of 1.24. The stock has a market cap of $11.78 billion, a PE ratio of 35.97, a P/E/G ratio of 0.76 and a beta of 1.79. BrightSpring Health Services has a twelve month low of $19.01 and a twelve month high of $73.75.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $60.00 target price on shares of BrightSpring Health Services in a research note on Monday, May 4th. Wall Street Zen downgraded shares of BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 4th. UBS Group boosted their price target on shares of BrightSpring Health Services from $63.00 to $85.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. Stephens upped their price objective on shares of BrightSpring Health Services from $53.00 to $64.00 and gave the company an “overweight” rating in a research note on Monday, May 4th. Finally, Mizuho upped their price objective on shares of BrightSpring Health Services from $52.00 to $61.00 and gave the company an “outperform” rating in a research note on Tuesday, May 5th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $70.12.

Insider Activity

In related news, insider Lisa A. Nalley sold 35,000 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $58.75, for a total value of $2,056,250.00. Following the sale, the insider directly owned 131,948 shares in the company, valued at approximately $7,751,945. The trade was a 20.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jon B. Rousseau sold 130,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $58.75, for a total transaction of $7,637,500.00. Following the completion of the transaction, the insider directly owned 1,194,503 shares in the company, valued at $70,177,051.25. The trade was a 9.82% decrease in their position. The SEC filing for this sale provides additional information. 2.80% of the stock is currently owned by insiders.

Hedge Funds Weigh In On BrightSpring Health Services

Several large investors have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC purchased a new position in shares of BrightSpring Health Services during the 2nd quarter worth approximately $43,000. Los Angeles Capital Management LLC purchased a new stake in BrightSpring Health Services in the fourth quarter valued at approximately $115,000. Sandia Investment Management LP acquired a new position in BrightSpring Health Services during the second quarter worth $118,000. Northwestern Mutual Wealth Management Co. lifted its stake in BrightSpring Health Services by 1,371.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,120 shares of the company’s stock worth $192,000 after purchasing an additional 4,772 shares in the last quarter. Finally, PEAK6 LLC purchased a new position in shares of BrightSpring Health Services during the fourth quarter worth $206,000.

Key BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Second-quarter adjusted earnings were $0.45 per share, exceeding consensus estimates of $0.40 and more than doubling the $0.22 reported a year earlier. Revenue increased 23% year over year to $3.87 billion, also above the $3.66 billion analyst estimate. BrightSpring Health Services Q2 earnings report
• Positive Sentiment: Management increased its full-year 2026 revenue guidance to $15.1 billion-$15.4 billion, slightly above the roughly $15.1 billion consensus forecast. The company also projected 2026 adjusted EBITDA of $820 million-$845 million. BrightSpring reports Q2 results and raises guidance
• Positive Sentiment: The company is targeting leverage below 2x, which could improve financial flexibility and reduce balance-sheet concerns over time. BrightSpring projects EBITDA and targets lower leverage
• Neutral Sentiment: Investors will likely focus on management’s comments regarding operating trends, integration and the pace of deleveraging during the earnings call. BrightSpring Q2 2026 earnings call transcript
• Negative Sentiment: Despite the earnings and revenue beats, the full-year revenue outlook was only modestly above expectations, while no specific full-year EPS guidance was provided in the available release. That may have disappointed investors seeking a larger upgrade to profitability expectations.
• Negative Sentiment: At about 42 times earnings, BrightSpring’s valuation leaves limited room for execution concerns or profit-taking. The company also operates with meaningful leverage, making debt reduction and cash flow important factors for the stock.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.